text.skipToContent text.skipToNavigation
+49 (0)281 9887 0

{{ addToCartData.mixPtRmWarning }}

Do you want to proceed?
{{requestQuote.productName}}; {{requestQuote.form.productCode}}

Thank you

We will respond to your enquiry shortly.

Something went wrong, please try again later.

 Bulk Order
{{ cartItemsCount }} 0
If not, click 'cancel'. You can also save this item for later.
Cancel
{{ cartItemsCount }} 0
If not, click 'cancel'. You can also save this item for later.
Cancel
Popular Regions
All Regions
+49 (0)281 9887 0

Neurodegenerative diseases research tools

Discover the latest neural cells and models, research chemicals and reference standards to support your research into neurodegenerative diseases.

 

neuron-img-950x350-min.jpg

Explore TRC neurology research chemicals

TRC's high-quality research chemicals support foundational research and breakthrough discovery in Parkinson's, Alzheimer's, Huntington's disease, Multiple Sclerosis and other neurological diseases.

View range
stem-cell-img-950x350-min.jpg

Discover a range of cells and microbial materials

A reliable selection of cells and microbial reference materials remains at the heart of incredible breakthroughs in neuro research. Select high-quality research tools, use authenticated ATCC cells.

Explore now
custom-chemical-synthesis-solutions-img-min.jpg

Custom chemical synthesis solutions

TRC specializes in solving complex chemical synthesis problems and manufacturing high-quality chemicals in custom pack sizes. TRC supports the global scientific community across 120+ countries.

Contact us

  • Explore TRC neurology research chemicals

  • Discover a range of cells and microbial materials

  • Custom chemical synthesis solutions

{{ article.title }}

{{ article.text }}

{{ article.ctaText }}

{{ article.title }}

{{ article.text }}

{{ article.ctaText }}

Stay in the know with our latest Neurodegenerative diseases resources:

<p>Promising new drug target found for Parkinson’s disease.</p>

Parkinson's article

Promising new drug target found for Parkinson’s disease.
Targeting neuroinflammation in neuroscience research.

Neuroinflammation white paper

Targeting neuroinflammation in neuroscience research.
New drug reverses synapse loss in Alzheimer's mouse models.

Alzheimer's article

New drug reverses synapse loss in Alzheimer's mouse models.
Can one Alzheimer’s-resistant brain offer us clues for new treatments?

Alzheimer's APOE article

Can one Alzheimer’s-resistant brain offer us clues for new treatments?
Punchout session timeout warning

Your punchout session will expire in1 min59 sec.

Select "Continue session" to extend your session.